Curated factual news snippets — click through to read full articles
[Home] [Topics]
[TZ: Australia/Sydney]
    [Raise a Problem] [About] [Admin]

    Akeso lung cancer drug shines in trials, boosting hopes in US$20b market

    --------------------------------------------------------------------
    Source: South China Morning Post
    Published: 2026-06-01 20:49 UTC+10:00
    Section: Nomura
    Factuality Score: 92
    Opinion Category: Neutral
    Topics: Health, Asia, Economy & Finance, China, Financial Markets, Drugs, Business & Economy, Asia Pacific
    --------------------------------------------------------------------
    Snippet:
    Ivonescimab phase three trials reduce death risk by 34 per cent, as analysts predict it could transform non-small cell lung cancer therapy
    --------------------------------------------------------------------
    >>> Read full article at South China Morning Post <<<
    <-- Back to Home

    This site displays brief snippets of news articles and links to the original publishers. Click the source link to read the full article on their site.

    Powered by Nebulex Pty Ltd Australia

    < >
    [Close]